{"id":"https://openalex.org/W4246836062","doi":"https://doi.org/10.1016/s1473-3099(19)30440-2","title":"Research brief","display_name":"Research brief","publication_year":2019,"publication_date":"2019-08-29","ids":{"openalex":"https://openalex.org/W4246836062","doi":"https://doi.org/10.1016/s1473-3099(19)30440-2"},"language":"en","primary_location":{"id":"doi:10.1016/s1473-3099(19)30440-2","doi":"https://doi.org/10.1016/s1473-3099(19)30440-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1473-3099(19)30440-2","pdf_url":null,"source":{"id":"https://openalex.org/S23772524","display_name":"The Lancet Infectious Diseases","issn_l":"1473-3099","issn":["1473-3099","1474-4457"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002755707","display_name":"Sean Cleghorn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Sean Cleghorn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5002755707"],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.38126098,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"19","issue":"9","first_page":"939","last_page":"939"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11581","display_name":"Viral Infections and Outbreaks Research","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.045899998396635056,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nitazoxanide","display_name":"nitazoxanide","score":1.0},{"id":"https://openalex.org/keywords/ebola-virus","display_name":"Ebola virus","score":0.9449999928474426},{"id":"https://openalex.org/keywords/host-directed-therapy","display_name":"host-directed therapy","score":0.9580000042915344},{"id":"https://openalex.org/keywords/rig-i","display_name":"RIG-I","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pkr","display_name":"PKR","score":0.9929999709129333},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.6050000190734863},{"id":"https://openalex.org/keywords/virus-host-interactions","display_name":"host-virus interaction","score":0.4860000014305115},{"id":"https://openalex.org/keywords/antiviral-drug-repurposing","display_name":"antiviral drug repurposing","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C2777276848","wikidata":"https://www.wikidata.org/wiki/Q2943789","display_name":"Nitazoxanide","level":2,"score":0.99625563621521},{"id":"https://openalex.org/C2777469322","wikidata":"https://www.wikidata.org/wiki/Q8064876","display_name":"Ebola virus","level":3,"score":0.7734192609786987},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.6614798903465271},{"id":"https://openalex.org/C2777795018","wikidata":"https://www.wikidata.org/wiki/Q134734","display_name":"Cryptosporidium parvum","level":2,"score":0.6438188552856445},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6370323300361633},{"id":"https://openalex.org/C161238802","wikidata":"https://www.wikidata.org/wiki/Q14905690","display_name":"Protein kinase R","level":5,"score":0.5687702298164368},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5339518785476685},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.46152156591415405},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4389059245586395},{"id":"https://openalex.org/C2778877831","wikidata":"https://www.wikidata.org/wiki/Q133078","display_name":"Cryptosporidium","level":3,"score":0.41826778650283813},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3853965699672699},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32315999269485474},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3212389349937439},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.19785460829734802},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1355101466178894},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.08045512437820435},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.07341364026069641},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C90934575","wikidata":"https://www.wikidata.org/wiki/Q6593810","display_name":"Mitogen-activated protein kinase kinase","level":4,"score":0.0},{"id":"https://openalex.org/C61716771","wikidata":"https://www.wikidata.org/wiki/Q496","display_name":"Feces","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1473-3099(19)30440-2","doi":"https://doi.org/10.1016/s1473-3099(19)30440-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1473-3099(19)30440-2","pdf_url":null,"source":{"id":"https://openalex.org/S23772524","display_name":"The Lancet Infectious Diseases","issn_l":"1473-3099","issn":["1473-3099","1474-4457"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2969176196","https://openalex.org/W3186537778","https://openalex.org/W2940834995","https://openalex.org/W2756484115","https://openalex.org/W2025902163","https://openalex.org/W2084368049","https://openalex.org/W2604775756","https://openalex.org/W2015999301","https://openalex.org/W7098161203","https://openalex.org/W2061482476"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-08-28T12:50:07.497085","created_date":"2022-05-12T00:00:00"}